161 related articles for article (PubMed ID: 12942114)
21. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer in Canada: changing patterns in incidence and mortality.
Liu S; Semenciw R; Probert A; Mao Y
Int J Gynecol Cancer; 2001; 11(1):24-31. PubMed ID: 11285030
[TBL] [Abstract][Full Text] [Related]
23. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements.
Vesterinen E; Forss M; Nieminen U
Gynecol Oncol; 1989 Apr; 33(1):49-53. PubMed ID: 2703167
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Sogaard M; Patumanond J; Khunamornpong S; Chandacham A; Suprasert P
Asian Pac J Cancer Prev; 2013; 14(9):5355-60. PubMed ID: 24175825
[TBL] [Abstract][Full Text] [Related]
25. Cancer of the uterine cervix in Norway by histologic type, 1970-84.
Eide TJ
J Natl Cancer Inst; 1987 Aug; 79(2):199-205. PubMed ID: 3474452
[TBL] [Abstract][Full Text] [Related]
26. Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.
van de Nieuwenhof HP; Massuger LF; de Hullu JA; van Ham MA; van Dijck JA; Siebers AG; Bekkers RL
Br J Cancer; 2008 Jan; 98(1):165-7. PubMed ID: 18182979
[TBL] [Abstract][Full Text] [Related]
27. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
28. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
29. [Cervical cancer in the young woman].
Marie G; Barjot P; Crouet H; Mace-Lesech J; Dommesent D; Uzan M
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):743-7. PubMed ID: 8308200
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival.
Davy ML; Dodd TJ; Luke CG; Roder DM
Obstet Gynecol; 2003 Jan; 101(1):38-45. PubMed ID: 12517643
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of screening for cervical squamous and adenocarcinoma. The Dutch experience.
Boon ME; de Graaff Guilloud JC; Kok LP; Olthof PM; van Erp EJ
Cancer; 1987 Feb; 59(4):862-6. PubMed ID: 3802045
[TBL] [Abstract][Full Text] [Related]
32. Incidence, mortality and determinants of survival from cervical cancer in Northwest Russia: a registry-based cohort study.
Grjibovski AM; Dubovichenko D; Saduakassova S; Zhatkanbayeva G; Omarova G; Shalgumbayeva G; Valkova L; Valkov MY
Int Health; 2018 Mar; 10(2):92-99. PubMed ID: 29432549
[TBL] [Abstract][Full Text] [Related]
33. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
Sherman ME; Wang SS; Carreon J; Devesa SS
Cancer; 2005 Mar; 103(6):1258-64. PubMed ID: 15693030
[TBL] [Abstract][Full Text] [Related]
34. The clinicopathologic significance of laminin-5 gamma2 chain expression in cervical squamous carcinoma and adenocarcinoma.
Andersson S; Hellström AC; Angström T; Stendahl U; Auer G; Wallin KL
Int J Gynecol Cancer; 2005; 15(6):1065-72. PubMed ID: 16343183
[TBL] [Abstract][Full Text] [Related]
35. [Cervical cancer before 35 years of age: epidemiological and prognostic aspects. Retrospective study of 46 cases of cervical cancer before 35 years of age in a series of 449 cases in stages IA2 and IV].
Saint-Paul MT; Brémond A; Rochet Y
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):737-42. PubMed ID: 8308199
[TBL] [Abstract][Full Text] [Related]
36. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix.
Chen J; Macdonald OK; Gaffney DK
Obstet Gynecol; 2008 Jun; 111(6):1394-402. PubMed ID: 18515524
[TBL] [Abstract][Full Text] [Related]
37. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old.
Chan PG; Sung HY; Sawaya GF
Obstet Gynecol; 2003 Oct; 102(4):765-73. PubMed ID: 14551007
[TBL] [Abstract][Full Text] [Related]
38. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
39. [Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?].
Recoules-Arche A; Rouzier R; Rey A; Villefranque V; Haie-Meder C; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2004 Feb; 32(2):116-21. PubMed ID: 15123133
[TBL] [Abstract][Full Text] [Related]
40. Prognosis and treatment of primary adenocarcinoma and adenosquamous cell carcinoma of the uterine cervix.
Pekin T; Kavak Z; Yildizhan B; Kaya H
Eur J Gynaecol Oncol; 2001; 22(2):160-3. PubMed ID: 11446486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
